期刊
HEMATOLOGY REPORTS
卷 14, 期 2, 页码 95-102出版社
MDPI
DOI: 10.3390/hematolrep14020014
关键词
COVID-19; hematological changes; thrombosis; hematological diseases
类别
COVID-19 infection can cause hematological changes, most of which are non-specific but have prognostic value. Patients with certain hematological diseases and those receiving aggressive immunosuppressive therapy are more susceptible to COVID-19, while most patients with other chronic hematological conditions do not have a significantly higher risk of infection compared to the general population.
COVID-19 is a systemic infection that leads to multisystem affection, including hematological changes. On the other hand, the patients who have certain hematological diseases are more susceptible to COVID-19 infection. The aim of this review is to examine the wide spectrum of hematological changes that are reported to occur due to COVID-19 infection. Most of the studies over the past year mainly show that most of these changes are mainly non-specific, but are of prognostic value. On the other hand, the susceptibility of hematological patients to COVID-19 infection and complications remains questionable. Patients with certain hematological diseases (including malignancy) and those who are treated by aggressive immunosuppressive therapy have shown higher rates of COVID-19 infection and complications. On the other hand, for most of the patients suffering from other chronic hematological conditions, no evidence has shown a greater risk of infection, compared to the general population.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据